If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

Share Price is delayed by 15 minutes
Get Live Data
2,603.00    -21.00 (-0.80%)
Bid:
2,592.00
Ask:
2,593.00
Spread: 1.00 (0.039%)
Market Cap: £26.17b
III Live PriceLast checked at - London Stock Exchange

Intraday 3i Group Share Chart

Directorate Change

24 Oct 2018 09:14

RNS Number : 0179F
3i Group PLC
24 October 2018
 

 

3i Group plc: non-executive Director appointment

 

Coline McConville

3i Group plc announces the appointment of Coline McConville as a non-executive Director with effect from 1 November 2018.

 

Coline McConville is currently a non-executive director of Fevertree Drinks plc, Inchcape plc and Travis Perkins plc. She is also a member of the Supervisory Board of Tui AG. She was previously a non-executive director of Tui Travel plc, UTV Media plc, Wembley National Stadium Limited, Shed Media plc and HBOS plc.

 

Prior to that Coline was Chief Operating Officer and Chief Executive Officer Europe of Clear Channel International Limited and had previously worked for McKinsey.

 

Simon Thompson, 3i Chairman, said: "We are very pleased to announce Coline's appointment to 3i's Board. She brings extensive commercial experience in a variety of sectors and significant board experience."

 

Coline McConville commented: "I am very pleased to be joining 3i as the firm continues to focus on successfully executing its strategic plan. 3i has a strong management team, a strong institutional franchise and is well placed to continue to generate value for its shareholders."

 

There are no further matters to be disclosed in accordance with paragraph 9.6.13R of the UKLA's Listing Rules.

 

 

-Ends-

 

For further information, contact:

Kathryn van der Kroft 020 7975 3021

Communications Director

 

Silvia Santoro 020 7975 3258

Investor Relations Director

 

Notes to Editors:

 

About 3i

 

3i is a leading international investment manager focused on mid-market private equity and infrastructure. Its core investment markets are northern Europe and North America. For further information, please visit: www.3i.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAMIBPTMBBTMBP
Date   Source Headline
31st Aug 20233:52 pmRNSDirector/PDMR Shareholding
1st Aug 202311:40 amRNSDirector/PDMR Shareholding
31st Jul 20234:31 pmRNSTotal Voting Rights
31st Jul 20234:27 pmRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSFY2024 Q1 performance update
3rd Jul 202310:25 amRNSPortfolio Update
30th Jun 20233:43 pmRNSTotal Voting Rights
30th Jun 20233:37 pmRNSDirector/PDMR Shareholding
30th Jun 202311:01 amRNSDirector/PDMR Shareholding
29th Jun 20235:00 pmRNSDirectorate Change
29th Jun 20233:46 pmRNSDirector/PDMR Shareholding
29th Jun 20233:31 pmRNSDoc re. AGM Resolutions
29th Jun 20233:30 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM and portfolio update
28th Jun 20232:34 pmRNSDirector/PDMR Shareholding
12th Jun 20232:33 pmRNSPublication of a Prospectus
9th Jun 20239:44 amRNSBlock listing Interim Review
8th Jun 20232:51 pmRNSDirector/PDMR Shareholding
7th Jun 202311:21 amRNSDTR 6.3.5
5th Jun 20233:30 pmRNSDirector/PDMR Shareholding
2nd Jun 20234:12 pmRNSDirector/PDMR Shareholding
31st May 20234:36 pmRNSTotal Voting Rights
31st May 20234:33 pmRNSDirector/PDMR Shareholding
24th May 202310:24 amRNSDoc re. 2023 Notice of AGM
18th May 202311:02 amRNSDoc re. 2023 Annual Report and Accounts
12th May 20232:47 pmRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSResults for the year to 31 March 2023
28th Apr 20234:41 pmRNSTotal Voting Rights
28th Apr 20234:40 pmRNSDirector/PDMR Shareholding
3rd Apr 202310:38 amRNSPortfolio Update
31st Mar 20234:37 pmRNSTotal Voting Rights
31st Mar 20234:34 pmRNSDirector/PDMR Shareholding
28th Mar 202311:36 amRNSDirector/PDMR Shareholding
24th Mar 20232:13 pmRNSDirector/PDMR Shareholding
24th Mar 202312:14 pmRNSDirector/PDMR Shareholding
24th Mar 202312:11 pmRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amRNSAction Capital Markets Seminar & portfolio update
15th Mar 20232:53 pmRNSHolding(s) in Company
28th Feb 20233:41 pmRNSDirector/PDMR Shareholding
28th Feb 20233:31 pmRNSTotal Voting Rights
10th Feb 20231:28 pmRNSHolding(s) in Company
8th Feb 20239:54 amRNSHolding(s) in Company
6th Feb 20232:10 pmRNSDirector/PDMR Shareholding
2nd Feb 202310:44 amRNSDirector/PDMR Shareholding
1st Feb 20233:32 pmRNSDirector/PDMR Shareholding
31st Jan 20234:32 pmRNSTotal Voting Rights
31st Jan 20234:30 pmRNSDirector/PDMR Shareholding
26th Jan 20237:00 amRNS3i Group plc FY2023 Q3 performance update
25th Jan 20233:57 pmRNSHolding(s) in Company
4th Jan 20234:42 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.